The National Committee for Clinical Research (NCCR), Ministry of Health, is spearheading various initiatives to enhance and regulate the quality of biomedical research and clinical research practice in Malaysia.

The NCCR is made up of member representatives and experts from the Ministry of Health (MOH), various national Universities, the Malaysian Pharmaceutical Society (MPS), the Pharmaceutical Association of Malaysia (PhAMA), the Malaysian Organisation of Pharmaceutical Industries (MOPI), as well as other Non-Governmental Organisations. This composition of member representatives reflects the on-going “smart-partnerships” amongst the various stake-holders with interests in quality clinical research in Malaysia.